• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
FRE

FIREBRICK PHARMA LIMITED - Announcements

5.26% ! 8.0¢
Market Cap $17.27M  !

Firebrick Pharma (ASX:FRE) is an Australian pharmaceutical developer focused on... Firebrick Pharma (ASX:FRE) is an Australian pharmaceutical developer focused on developing and commercializing novel formulations and uses of povidone-iodine. After more than 10 years of R&D including multiple human clinical trials, Firebrick's first product, Nasodine® Nasal Spray, is now available for sale in USA and Singapore.More

Corporate Spotlight

Firebrick Pharma (ASX:FRE) is an Australian pharmaceutical developer focused on developing and commercializing novel formulations and uses of povidone-iodine. After more than 10 years of R&D including multiple human clinical trials, Firebrick's first product, Nasodine® Nasal Spray, is now available
View the full Corporate Spotlight arrow Created with Sketch.

FIREBRICK PHARMA - JUNE INVESTOR WEBINAR

Announcements



Filters [Clear]
  • Price Sensitive: Yes
FRE June 2025 Quarterly Activity Report & Appendix 4CPRICE SENSITIVE23/07/25 download Created with Sketch. 361.44KB
FRE Firebrick Closes Placement at $0.2 milliionPRICE SENSITIVE26/06/25 download Created with Sketch. 248.26KB
FRE Trading HaltPRICE SENSITIVE24/06/25 download Created with Sketch. 332.05KB
FRE Withdrawal of Share PlacementPRICE SENSITIVE06/06/25 download Created with Sketch. 95.37KB
FRE Trading HaltPRICE SENSITIVE05/06/25 download Created with Sketch. 329.81KB
FRE March 2025 Quarterly Activity Report & Appendix 4CPRICE SENSITIVE16/04/25 download Created with Sketch. 603.25KB
FRE FRE secures Strategic Investment from Philippines PartnerPRICE SENSITIVE04/03/25 download Created with Sketch. 299.72KB
FRE Trading HaltPRICE SENSITIVE28/02/25 download Created with Sketch. 618.38KB
FRE Appendix 4D & Half-Year Financial Report to 31 December 2024PRICE SENSITIVE20/02/25 download Created with Sketch. 832.34KB
FRE December 2024 Quarterly Activity Report & Appendix 4CPRICE SENSITIVE23/01/25 download Created with Sketch. 304.67KB
FRE Nasodine Retail Pharmacy Launch in SingaporePRICE SENSITIVE25/11/24 download Created with Sketch. 116.21KB
FRE Agreement Signed to Market Nasodine to HCPs in SingaporePRICE SENSITIVE31/10/24 download Created with Sketch. 126.13KB
FRE September 2024 Quarterly Activity Report & Appendix 4CPRICE SENSITIVE22/10/24 download Created with Sketch. 324.5KB
FRE Completion of Share Purchase PlanPRICE SENSITIVE10/10/24 download Created with Sketch. 112.82KB
FRE Firebrick receives $0.9 million R&D Tax IncentivePRICE SENSITIVE23/09/24 download Created with Sketch. 103.93KB
FRE Share Purchase PlanPRICE SENSITIVE12/09/24 download Created with Sketch. 107.49KB
FRE Appendix 4E and Annual Report 30 June 2024PRICE SENSITIVE30/08/24 download Created with Sketch. 2.11MB
FRE New agreement allows Nasodine launch in PhilippinesPRICE SENSITIVE15/08/24 download Created with Sketch. 142.19KB
FRE June 2024 Quarterly Activity Report & Appendix 4CPRICE SENSITIVE30/07/24 download Created with Sketch. 366.32KB
FRE Firebrick Launches Nasodine in SingaporePRICE SENSITIVE13/06/24 download Created with Sketch. 300.06KB
FRE Firebrick Raises $800,000 via PlacementPRICE SENSITIVE17/05/24 download Created with Sketch. 270.08KB
FRE March 2024 Quarterly Activity Report & Appendix 4CPRICE SENSITIVE23/04/24 download Created with Sketch. 346.54KB
FRE Nasodine Nasal Spray Launch in the USAPRICE SENSITIVE17/04/24 download Created with Sketch. 1.11MB
FRE Appendix 4D & Half-Year Financial Report to 31 December 2023PRICE SENSITIVE28/02/24 download Created with Sketch. 1.09MB
FRE December 2023 Quarterly Activity Report & Appendix 4CPRICE SENSITIVE23/01/24 download Created with Sketch. 379.29KB
FRE Firebrick Investor UpdatePRICE SENSITIVE15/11/23 download Created with Sketch. 176.44KB
FRE Firebrick Receives $1.81m R&D Tax IncentivePRICE SENSITIVE31/10/23 download Created with Sketch. 146.31KB
FRE September 2023 Quarterly Activity Report & Appendix 4CPRICE SENSITIVE27/10/23 download Created with Sketch. 229.96KB
FRE Update on Nasodine Trial and Forward PlansPRICE SENSITIVE03/10/23 download Created with Sketch. 163.23KB
FRE Phase 3 Common Cold Trial ResultsPRICE SENSITIVE13/09/23 download Created with Sketch. 185.34KB
FRE Trading HaltPRICE SENSITIVE11/09/23 download Created with Sketch. 614.24KB
FRE Appendix 4E & Annual Report FY23PRICE SENSITIVE29/08/23 download Created with Sketch. 1.93MB
FRE Response to ASX Price and Volume QueryPRICE SENSITIVE28/08/23 download Created with Sketch. 793.97KB
FRE Firebrick Phase 3 Trial Closes with 500 SubjectsPRICE SENSITIVE09/08/23 download Created with Sketch. 109.26KB
FRE Firebrick Covid-19 Trial Achieves Primary EndpointPRICE SENSITIVE07/08/23 download Created with Sketch. 151.09KB
FRE June 2023 Quarterly Activity Report & Appendix 4CPRICE SENSITIVE27/07/23 download Created with Sketch. 236.73KB
FRE Nasodine Phase 3 Clinical Trial Surpasses 80% RecruitmentPRICE SENSITIVE31/05/23 download Created with Sketch. 160.77KB
FRE Firebrick Raises $1 million via PlacementPRICE SENSITIVE01/05/23 download Created with Sketch. 151.07KB
FRE March 2023 Quarterly Activity Report & Appendix 4CPRICE SENSITIVE20/04/23 download Created with Sketch. 258.05KB
FRE Nasodine COVID-19 Trial Concludes RecruitmentPRICE SENSITIVE03/04/23 download Created with Sketch. 325.78KB
FRE Firebrick Pharma's Phase 3 Trial of Nasodine ResumesPRICE SENSITIVE21/03/23 download Created with Sketch. 379.02KB
FRE FRE files EU Paediatric Investigation Plan for NasodinePRICE SENSITIVE21/02/23 download Created with Sketch. 148.88KB
FRE Appendix 4D & Half Yearly Report and AccountsPRICE SENSITIVE17/02/23 download Created with Sketch. 6.77MB
FRE December 2022 Quarterly Activity Report & Appendix 4CPRICE SENSITIVE19/01/23 download Created with Sketch. 366.28KB
FRE Nasodine Composition Patent Accepted in AustraliaPRICE SENSITIVE14/11/22 download Created with Sketch. 154.31KB
FRE Firebrick Receives $1.08m R&D Tax IncentivePRICE SENSITIVE09/11/22 download Created with Sketch. 138.29KB
FRE September 2022 Quarterly Activity Report & Appendix 4CPRICE SENSITIVE31/10/22 download Created with Sketch. 352.35KB
FRE Appendix 4E & Annual ReportPRICE SENSITIVE23/08/22 download Created with Sketch. 7.72MB
FRE June 2022 Quarterly Activity Report & Appendix 4CPRICE SENSITIVE29/07/22 download Created with Sketch. 343.93KB
FRE Outcome of s60 appeal for Nasodine and next stepsPRICE SENSITIVE07/07/22 download Created with Sketch. 137.21KB
FRE Trading HaltPRICE SENSITIVE07/07/22 download Created with Sketch. 615.26KB
FRE Firebrick starts Phase 3 common cold trial of NasodinePRICE SENSITIVE03/05/22 download Created with Sketch. 157.28KB
FRE March 2022 Quarterly Activity Report & Appendix 4CPRICE SENSITIVE26/04/22 download Created with Sketch. 370.37KB
FRE Firebrick starts COVID-19 trial of NasodinePRICE SENSITIVE26/04/22 download Created with Sketch. 167.62KB
FRE 31 December Interim Financial Report & Appendix 4DPRICE SENSITIVE11/02/22 download Created with Sketch. 466.51KB
FRE June 2025 Quarterly Activity Report & Appendix 4C
23/07/25PRICE SENSITIVE download Created with Sketch. 361.44KB
FRE Firebrick Closes Placement at $0.2 milliion
26/06/25PRICE SENSITIVE download Created with Sketch. 248.26KB
FRE Trading Halt
24/06/25PRICE SENSITIVE download Created with Sketch. 332.05KB
FRE Withdrawal of Share Placement
06/06/25PRICE SENSITIVE download Created with Sketch. 95.37KB
FRE Trading Halt
05/06/25PRICE SENSITIVE download Created with Sketch. 329.81KB
FRE March 2025 Quarterly Activity Report & Appendix 4C
16/04/25PRICE SENSITIVE download Created with Sketch. 603.25KB
FRE FRE secures Strategic Investment from Philippines Partner
04/03/25PRICE SENSITIVE download Created with Sketch. 299.72KB
FRE Trading Halt
28/02/25PRICE SENSITIVE download Created with Sketch. 618.38KB
FRE Appendix 4D & Half-Year Financial Report to 31 December 2024
20/02/25PRICE SENSITIVE download Created with Sketch. 832.34KB
FRE December 2024 Quarterly Activity Report & Appendix 4C
23/01/25PRICE SENSITIVE download Created with Sketch. 304.67KB
FRE Nasodine Retail Pharmacy Launch in Singapore
25/11/24PRICE SENSITIVE download Created with Sketch. 116.21KB
FRE Agreement Signed to Market Nasodine to HCPs in Singapore
31/10/24PRICE SENSITIVE download Created with Sketch. 126.13KB
FRE September 2024 Quarterly Activity Report & Appendix 4C
22/10/24PRICE SENSITIVE download Created with Sketch. 324.5KB
FRE Completion of Share Purchase Plan
10/10/24PRICE SENSITIVE download Created with Sketch. 112.82KB
FRE Firebrick receives $0.9 million R&D Tax Incentive
23/09/24PRICE SENSITIVE download Created with Sketch. 103.93KB
FRE Share Purchase Plan
12/09/24PRICE SENSITIVE download Created with Sketch. 107.49KB
FRE Appendix 4E and Annual Report 30 June 2024
30/08/24PRICE SENSITIVE download Created with Sketch. 2.11MB
FRE New agreement allows Nasodine launch in Philippines
15/08/24PRICE SENSITIVE download Created with Sketch. 142.19KB
FRE June 2024 Quarterly Activity Report & Appendix 4C
30/07/24PRICE SENSITIVE download Created with Sketch. 366.32KB
FRE Firebrick Launches Nasodine in Singapore
13/06/24PRICE SENSITIVE download Created with Sketch. 300.06KB
FRE Firebrick Raises $800,000 via Placement
17/05/24PRICE SENSITIVE download Created with Sketch. 270.08KB
FRE March 2024 Quarterly Activity Report & Appendix 4C
23/04/24PRICE SENSITIVE download Created with Sketch. 346.54KB
FRE Nasodine Nasal Spray Launch in the USA
17/04/24PRICE SENSITIVE download Created with Sketch. 1.11MB
FRE Appendix 4D & Half-Year Financial Report to 31 December 2023
28/02/24PRICE SENSITIVE download Created with Sketch. 1.09MB
FRE December 2023 Quarterly Activity Report & Appendix 4C
23/01/24PRICE SENSITIVE download Created with Sketch. 379.29KB
FRE Firebrick Investor Update
15/11/23PRICE SENSITIVE download Created with Sketch. 176.44KB
FRE Firebrick Receives $1.81m R&D Tax Incentive
31/10/23PRICE SENSITIVE download Created with Sketch. 146.31KB
FRE September 2023 Quarterly Activity Report & Appendix 4C
27/10/23PRICE SENSITIVE download Created with Sketch. 229.96KB
FRE Update on Nasodine Trial and Forward Plans
03/10/23PRICE SENSITIVE download Created with Sketch. 163.23KB
FRE Phase 3 Common Cold Trial Results
13/09/23PRICE SENSITIVE download Created with Sketch. 185.34KB
FRE Trading Halt
11/09/23PRICE SENSITIVE download Created with Sketch. 614.24KB
FRE Appendix 4E & Annual Report FY23
29/08/23PRICE SENSITIVE download Created with Sketch. 1.93MB
FRE Response to ASX Price and Volume Query
28/08/23PRICE SENSITIVE download Created with Sketch. 793.97KB
FRE Firebrick Phase 3 Trial Closes with 500 Subjects
09/08/23PRICE SENSITIVE download Created with Sketch. 109.26KB
FRE Firebrick Covid-19 Trial Achieves Primary Endpoint
07/08/23PRICE SENSITIVE download Created with Sketch. 151.09KB
FRE June 2023 Quarterly Activity Report & Appendix 4C
27/07/23PRICE SENSITIVE download Created with Sketch. 236.73KB
FRE Nasodine Phase 3 Clinical Trial Surpasses 80% Recruitment
31/05/23PRICE SENSITIVE download Created with Sketch. 160.77KB
FRE Firebrick Raises $1 million via Placement
01/05/23PRICE SENSITIVE download Created with Sketch. 151.07KB
FRE March 2023 Quarterly Activity Report & Appendix 4C
20/04/23PRICE SENSITIVE download Created with Sketch. 258.05KB
FRE Nasodine COVID-19 Trial Concludes Recruitment
03/04/23PRICE SENSITIVE download Created with Sketch. 325.78KB
FRE Firebrick Pharma's Phase 3 Trial of Nasodine Resumes
21/03/23PRICE SENSITIVE download Created with Sketch. 379.02KB
FRE FRE files EU Paediatric Investigation Plan for Nasodine
21/02/23PRICE SENSITIVE download Created with Sketch. 148.88KB
FRE Appendix 4D & Half Yearly Report and Accounts
17/02/23PRICE SENSITIVE download Created with Sketch. 6.77MB
FRE December 2022 Quarterly Activity Report & Appendix 4C
19/01/23PRICE SENSITIVE download Created with Sketch. 366.28KB
FRE Nasodine Composition Patent Accepted in Australia
14/11/22PRICE SENSITIVE download Created with Sketch. 154.31KB
FRE Firebrick Receives $1.08m R&D Tax Incentive
09/11/22PRICE SENSITIVE download Created with Sketch. 138.29KB
FRE September 2022 Quarterly Activity Report & Appendix 4C
31/10/22PRICE SENSITIVE download Created with Sketch. 352.35KB
FRE Appendix 4E & Annual Report
23/08/22PRICE SENSITIVE download Created with Sketch. 7.72MB
FRE June 2022 Quarterly Activity Report & Appendix 4C
29/07/22PRICE SENSITIVE download Created with Sketch. 343.93KB
FRE Outcome of s60 appeal for Nasodine and next steps
07/07/22PRICE SENSITIVE download Created with Sketch. 137.21KB
FRE Trading Halt
07/07/22PRICE SENSITIVE download Created with Sketch. 615.26KB
FRE Firebrick starts Phase 3 common cold trial of Nasodine
03/05/22PRICE SENSITIVE download Created with Sketch. 157.28KB
FRE March 2022 Quarterly Activity Report & Appendix 4C
26/04/22PRICE SENSITIVE download Created with Sketch. 370.37KB
FRE Firebrick starts COVID-19 trial of Nasodine
26/04/22PRICE SENSITIVE download Created with Sketch. 167.62KB
FRE 31 December Interim Financial Report & Appendix 4D
11/02/22PRICE SENSITIVE download Created with Sketch. 466.51KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
8.0¢
Change
0.004(5.26%)
Mkt cap ! $17.27M
Open High Low Value Volume
7.5¢ 8.0¢ 7.5¢ $10.89K 142.4K

Buyers (Bids)

No. Vol. Price($)
3 191543 7.5¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 10000 1
View Market Depth
Last trade - 14.04pm 11/08/2025 (20 minute delay) ?
Last
8.0¢
  Change
0.004 ( 5.26 %)
Open High Low Volume
7.6¢ 8.0¢ 7.6¢ 61695
Last updated 14.02pm 11/08/2025 ?
FRE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.